[1]
M. A. Hassan Metwally, K. Diemer Frederiksen, and J. Overgaard, “Compliance and toxicity of the hypoxic radiosensitizer nimorazole in the treatment of patients with head and neck squamous cell carcinoma (HNSCC)”, AO, vol. 53, no. 5, pp. 654–661, May 2014.